ToddRGolubMD

Chief Scientific Officer

Dr. Golub is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
Danafarber Cancer Inst
44 Binney Street
Boston, MA 02115
Phone+1 617-632-4903

Boston Children’s Hospital/Boston Medical CenterResidency, Pediatrics, 1989 - 1991
University of Chicago Division of the Biological Sciences The Pritzker School of MedicineClass of 1989

PubMed

2 citations
BRD-810 is a highly selective MCL1 inhibitor with optimized in vivo clearance and robust efficacy in solid and hematological tumor models.
Ulrike Rauh, Guo Wei, Michael Serrano-Wu, Georgios Kosmidis, Stefan Kaulfuss
Nature Cancer. 2024-10-01
19 citations
Translation of non-canonical open reading frames as a cancer cell survival mechanism in childhood medulloblastoma.
Damon A Hofman, Jorge Ruiz-Orera, Ian Yannuzzi, Rakesh Murugesan, Adam Brown
Molecular Cell. 2024-01-18
46 citations
The PTPN2/PTPN1 inhibitor ABBV-CLS-484 unleashes potent anti-tumour immunity.
Christina K Baumgartner, Hakimeh Ebrahimi-Nik, Arvin Iracheta-Vellve, Keith M Hamel, Kira E Olander
Nature. 2023-10-01

Journal Articles

Selective Gene Dependencies in MYCN-Amplified Neuroblastoma Include the Core Transcriptional Regulatory Circuitry
William C Hahn, Todd R Golub, A Thomas Look, Adam D Durbin, Neekesh V Dharia, Kimberly Stegmaier, Nature
Genetic and Transcriptional Evolution Alters Cancer Cell Line Drug Response
Todd R Golub, Rameen Beroukhim, Pratiti Bandopadhayay, Nature
Retraction Note: Selective Killing of Cancer Cells by a Small Molecule Targeting the Stress Response to ROS
Stuart L Schreiber, Todd R Golub, Nature
Publisher Correction: Molecular Subtypes of Diffuse Large B Cell Lymphoma Are Associated with Distinct Pathogenic Mechanisms and Outcomes
Thomas M Habermann, Scott J Rodig, Rameen Beroukhim, Jeremiah A Wala, Andrew L Feldman, Todd R Golub, Margaret A Shipp, Nature
Join now to see all

Dana-Farber Cancer Institute Faculty Among World's Most Highly Cited ResearchersNovember 19th, 2024
René Salazar Joins Broad Institute as Chief Equity OfficerOctober 14th, 2021
40th Anniversary Recollections & PredictionsOctober 4th, 2021
Join now to see all

Broad Institute Center For Cancer Systems BiologyNational Cancer Institute2010–2012
Large Scale Gene Expression Analysis Of Cellular StatesNational Human Genome Research Institute2010–2011
Discovery Pipeline (2 Of 4)National Cancer Institute2009–2011
Molecular Signatures Of Melanoma: Predicting Response To Therapy &TargetingNational Cancer Institute2008–2011
Genomics And BioinformaticsNational Cancer Institute2007–2011
Connectivity MAP 100KNational Human Genome Research Institute2009–2010
Genomics And BioinformaticsNational Cancer Institute2006–2010
Anti-All Small Molecular Discovery VIA Chemical GenomicsNational Cancer Institute2006–2010
Discovery Of Inhibitors Of Anti-Apoptotic Protein A1National Institute On Drug Abuse2009
Signatures Of Kinase Activation In CancerNational Cancer Institute2004–2009
Discovery Pipeline (2 Of 4)National Cancer Institute2007–2008
Functional Genomic Dissection Of Refractory AnemiaNational Heart, Lung, And Blood Institute2005–2007
Genomic Expression Analysis Of Tumors After Radical ProstatectomyNational Cancer Institute2002
Core--GenomicsNational Cancer Institute2002
Core--Dna Microarray And BioinformaticsNational Cancer Institute2001–2002
Genomic Predictor Of Acute Lymphocytic Leukemia BiologyNational Cancer Institute2000–2002
Characterization Of TEL, A New Leukemogenic ETS ProteinNational Cancer Institute1997–2001
TEL Gene And LeukemiasNational Institute Of Diabetes And Digestive And Kidney Diseases1996–1998